Wednesday, June 29, 2011

E. coli outbreak may be traced to Egypt seeds (AP)

ROME � European food and disease prevention authorities said Wednesday they are investigating whether the E. coli outbreak in Germany and France may be traced back to fenugreek seeds imported from Egypt either in 2009 or last year.

The European Center for Disease Prevention and Control and the European Food Safety Authority said in a joint report that "there is still much uncertainty about whether this is truly the common cause of all the infections."

The report said "fenugreek seeds imported from Egypt either in 2009 and/or 2010 are implicated in both outbreaks." Fenugreek seeds are commonly used in the preparation of pickles and curry powders as well as Indian, Ethiopian and Yemeni cuisine.

However, further investigation was necessary, said the report.

The death toll in Europe's E. coli outbreak has risen by three to at least 47, according to German authorities. Germany's disease control center said earlier this week that 46 deaths have now been reported in the country. One person has died in Sweden.

In France, eight case have been reported so far. Seven people have been hospitalized in the Bordeaux region and another person was released.

The report said that a 2009 lot of fenugreek seeds appeared to be implicated in the outbreak in France and a 2010 lot in the German outbreak. But it said this possible link does not explain the case in Sweden, where no consumption of sprouts has been implicated.

Many questions were still unanswered about the source of the E. coli.

A further 119 cases have been reported in a total of 15 other countries. The source has been traced to a vegetable sprout farm in northern Germany.

The World Health Organization said it considers an outbreak in France separate. But it also said that, of the eight French cases, three of them carried the same bacterial strains as in Germany.

The report said the clinical picture of the French cases was similar to that of German cases.



Powered By WizardRSS.com | Full Text RSS Feed | Amazon Plugin | Settlement Statement | WordPress Tutorials

Lung cancer scans: False alarms amid lives saved (AP)

Full results of a big study that showed some smokers' lives could be saved by screening with lung scans now reveal more clearly what the risks are: There's a good chance of a false alarm.

Of those who got the recommended annual scans for three years, 4 out of 10 had a suspicious finding on at least one scan and were advised to have a follow-up test or biopsy. And more than 95 percent of them turned out to have nothing wrong.

The results out Wednesday give the first detailed look at the benefits and risks of screening longtime current or former smokers with special X-rays called CT scans. The government stopped the study last fall after seeing the scans were saving lives.

Most insurers don't cover the scans because no major groups currently recommend them.

"No one should rush off and get one of these scans for screening until we've thought more about it," said Dr. Christine Berg of the National Cancer Institute, the study's main sponsor.

But guidance on smoker screening is likely to change with the study's results, which may help the nation's 94 million current and former smokers decide whether to be screened.

"The question has changed to how are we going to do this," not whether we should, said Dr. Harold "Hal" Sox, a Dartmouth professor who used to head the government task force that shapes policy on screening tests. He wrote an editorial with the results, published online Wednesday by the New England Journal of Medicine.

The study tested CT scans versus ordinary chest X-rays in 53,454 people over 55 with more than 30 pack-years of smoking: a pack a day for 30 years or two packs for 15 years. No one knows if younger or less frequent smokers would benefit from screening.

The study used top medical centers around the nation and low-radiation-dose machines. It involved skilled doctors who did less invasive tests in place of many biopsies and had far lower death rates when they did operate for lung cancer than is usual. The lower risk of death among those screened with scans in the study reflects all these things.

"This is what happens when people get screened in the best of centers. When people start getting screened anyplace ... the results may not be, and are likely not to be, as good," warned Dr. Otis Brawley, chief medical officer of the American Cancer Society.

Numbers to know:

_Three. The number of scans, one each year, that showed benefit in this study. No one knows if a single scan or testing less often would help.

_Twenty percent. The reduction in the risk of dying from lung cancer among those given CT scans (356 deaths versus 443 in the X-ray group).

_Seven percent. The reduction in the risk of dying from any cause during the study (1,877 deaths in the CT group versus 2,000 in X-ray group).

_About 320. The number of people who would have to be scanned for three years to prevent a single death from lung cancer. That's impressive when compared to the 1,339 women in their 50s who would need to have mammograms for several years to avoid one breast cancer death. However, mammograms are cheaper and involve less radiation so the risks and benefits aren't quite the same.

_One percent. The odds of dying from surgery for lung cancer among those in the study. In general practice, it's 4 percent.

_$300 to $1,200. The average range of charges for a scan. At some private practices it's up to $2,500 and "there's a group in Hollywood that's charging more than that," said Berg, of the National Cancer Institute.

Researchers plan a cost-effectiveness study and may compare the benefit from scans to smoking cessation efforts.

"People should not take this positive study as `now it is safe to smoke,'" because it isn't, and quitting remains the best way to lower cancer risk, Brawley said.

The cancer society and other medical groups expect to have screening advice for the public "in a matter of months," said Dr. Bruce Johnson, a lung cancer expert at the Dana-Farber Cancer Institute in Boston and a board member of the American Society of Clinical Oncology, doctors who treat the disease.

"Can society afford it? This comes with a substantial cost," he said of screening.

___

Online:

New England Journal: http://www.nejm.org

Study Q&A: http://www.cancer.gov/newscenter/qa/2002/nlstqaQA

Video discussion: http://www.youtube.com/watch?vhY6GQnO75Mo

Screening info: http://www.cancer.gov/cancertopics/types/lung

___

Marilynn Marchione can be followed at http://twitter.com/MMarchioneAP



Powered By WizardRSS.com | Full Text RSS Feed | Amazon Plugin | Settlement Statement | WordPress Tutorials

Researchers analyze gene changes in ovarian cancer (AP)

LOS ANGELES � Researchers analyzing the genetic makeup of ovarian cancer tumors have found a gene mutation that is surprisingly frequent, suggesting it plays a key role in driving the cancer.

The finding, appearing in Thursday's issue of the journal Nature, may eventually lead to tests for earlier diagnosis of the disease and to better treatment. Ovarian cancer kills nearly 14,000 women in the United States each year. It's usually not spotted until at an advanced stage.

The gene sequencing was carried out by The Cancer Genome Atlas, a federally funded network of medical centers that analyzed 316 ovarian tumors.

Scientists found that 96 percent of the tumors had mutated TP53 genes. The mutations were not present in normal tissue from the patients, showing they arose within the tumors. Normally, the gene directs the cell how to make a protein that acts as a tumor suppressor, keeping cells from growing and dividing uncontrollably.

Alterations in nine other genes also played a role in ovarian cancer, though to a much lesser extent, the researchers reported. Among them were the BRCA1 and BRCA2 genes, which increase the risk of breast and ovarian cancer.

"In other cancers, there are usually several genes that are involved" on almost equal footing, said one of the study authors, Dr. David Wheeler of Baylor College of Medicine. "This is an unusual pattern."

The new work "is producing impressive insights into the biology" of ovarian cancer, Dr. Francis Collins, who heads the National Institutes of Health, said in a statement.

Among cancers, ovarian is the fifth leading cause of death among women. A regular pelvic exam is considered the best way to detect ovarian cancer early.

The Cancer Genome Atlas was launched in 2006 to unravel the genetic underpinning of cancer. The group mapped the genome of the most common form of brain cancer in 2008 and plans to do the same for 20 other types of cancers.

___

Online:

Nature journal: www.nature.com/nature

The Cancer Genome Atlas: http://cancergenome.nih.gov



Powered By WizardRSS.com | Full Text RSS Feed | Amazon Plugin | Settlement Statement | WordPress Tutorials

Report: More than 100 million suffer lasting pain (AP)

WASHINGTON � A new report finds at least 116 million U.S. adults experience long-lasting pain � the kind that lingers for weeks to months. Too often, they feel stigma rather than relief from a health care system poorly prepared to treat them.

The Institute of Medicine report shows chronic pain costs the nation even more than heart disease in medical bills, sick days and lost productivity.

The report calls effective pain management a moral imperative, and urges a series of steps to transform the field.

Barriers include health workers not properly trained to handle pain, and insurance that doesn't cover complex care. Law enforcement's fight against abuse of narcotic painkillers plays a role, too, but the report found that those medicines are safe and effective for the right patient.



Powered By WizardRSS.com | Full Text RSS Feed | Amazon Plugin | Settlement Statement | WordPress Tutorials